Chou, S., Alain, S., Cervera, C., Chemaly, R. F., Kotton, C. N., Lundgren, J., Papanicolaou, G. A., Pereira, M. R., Wu, J. J., Murray, R. A., Buss, N. E., & Fournier, M. (2023). Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients. The Journal of Infectious Diseases, 229(2), 413–421. https://doi.org/10.1093/infdis/jiad293
Columbia Affiliation:
Subjects:
Epidemiology and Management of Cytomegalovirus Infection
(OpenAlex Topic)
Polyomavirus-Associated Carcinogenesis and Clinical Manifestations
(OpenAlex Topic)
Herpesviruses: Epidemiology, Pathogenesis, and Management
(OpenAlex Topic)
Cytomegalovirus Infections
(MeSH)
Ribonucleosides
(MeSH)
Publication Type:
Article
Unique ID:
10.1093/infdis/jiad293
PMID:
Journal:
Publication Date:
Data Source:
PubMed
Source Link: